Work

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin given every three weeks in patients with advanced solid tumors

Year: 2013

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-013-9942-y

Authors: Cristiana Sessa, Gianluca Del Conte, Alexandre Christinat, Sara Cresta, Antonella Perotti, Elisa Gallerani, Pilar Lardelli, Carmen Kahatt, Vicente Alfaro, Jorge L. Iglesias, Carlos Fernández-Teruel, Luca Gianni

Institutions: Ospedale San Giovanni Bellinzona, Istituto Oncologico della Svizzera Italiana, IRCCS Ospedale San Raffaele, Fondazione IRCCS Istituto Nazionale dei Tumori, PharmaMar (Spain)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: PharmaMar

OpenAlex ID: W2020989264

FWCI: 1.21

Cites: 35

Cited by: 15

Related to: 10